Accessibility links
Pcr Patent NPR's Dan Charles reports that a patent used in DNA fingerprinting and throughout the biotech industry is being called into question. A court has ruled that the company that applied for the patent withheld crucial information from the U.S. Patent Office. The ruling could have widespread implications for the biotech industry by allowing competition into an area that has been dominated by the Swiss pharmaceutical firm Hoffmann-LaRoche.

All Things Considered

Pcr Patent

Heard on All Things Considered

Pcr Patent

Listen · 4:37
  • Download
  • <iframe src="https://www.npr.org/player/embed/1044518/44518" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">

NPR's Dan Charles reports that a patent used in DNA fingerprinting and throughout the biotech industry is being called into question. A court has ruled that the company that applied for the patent withheld crucial information from the U.S. Patent Office. The ruling could have widespread implications for the biotech industry by allowing competition into an area that has been dominated by the Swiss pharmaceutical firm Hoffmann-LaRoche.